Glaukos (GKOS) Stock Price

$94.05 0.3%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    8

  • Fundamental

    8

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Glaukos, AI stock picks, stock alerts and much more.

Sign up

GKOS AI Stock Analysis

AI stock analysis for GKOS is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Glaukos (GKOS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Glaukos (GKOS) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Glaukos (GKOS), currently trading at $94.05, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About GKOS

LSE

  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

  • Symbol

    GKOS

  • Market

    NYSE

  • Industry

    Medical - Devices

  • Market Cap

    5.4B

Similar Stocks

ABT Abbott Laboratories
ABT		 $128.6
0.4%
6
BSX Boston Scientific
BSX		 $106.8
0.3%
6
EW Edwards Lifesciences
EW		 $81.16
0.9%
6
MDT Medtronic
MDT		 $91.64
0.9%
6
SYK Stryker
SYK		 $400.4
0%
7

News

Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates

Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates
July 30, 2025. zacks.com
Glaukos Announces Second Quarter 2025 Financial Results

Glaukos Announces Second Quarter 2025 Financial Results
July 30, 2025. businesswire.com
Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks

Glaukos Ramps Up iDose TR, Battles Legacy and Reimbursement Risks
July 9, 2025. zacks.com
Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30

Glaukos to Release Second Quarter 2025 Financial Results after Market Close on July 30
July 9, 2025. businesswire.com

GKOS Alternative Data

Web Traffic

Glaukos receives an estimated 20498 monthly visitors to glaukos.com.

  • Web Traffic

    20498

  • Change from Previous Month

    5.6%

  • 3 Month Change

    9.3%

  • YoY Change

    9.3%

Twitter Followers

Glaukos has 1,631 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.

  • Twitter Followers

    1631

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    0.2%

  • YoY Change

    0.2%

Facebook Engagement

Glaukos has engaged 166 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    166

  • Daily Change

    2.4%

  • 1 Month Change

    58.2%

  • 3 Month Change

    30.7%

  • YoY Change

    30.7%

Instagram Followers

Glaukos has 3,507 Instagram Followers on its main Instagram account, up by 1.6% over the last month.

  • Instagram Followers

    3507

  • Daily Change

    0.1%

  • 1 Month Change

    1.6%

  • 3 Month Change

    5.4%

  • YoY Change

    5.4%

LinkedIn Followers

31,138 are following Glaukos on LinkedIn, up by 2% over the last month.

  • LinkedIn Followers

    31138

  • Daily Change

    0.1%

  • 1 Month Change

    2%

  • 3 Month Change

    6.5%

Job Postings

Glaukos currenly has an estimated 27 open job postings, up by 8% over the last month.

  • Job Postings

    27

  • Daily Change

    17.4%

  • 1 Month Change

    8%

  • 3 Month Change

    34.1%

  • YoY Change

    34.1%

LinkedIn Employees

According to LinkedIn, Glaukos has 961 employees, up by 2.5% over the last month.

  • LinkedIn Employees

    961

  • Daily Change

    0.2%

  • 1 Month Change

    2.5%

  • 3 Month Change

    5.3%

  • YoY Change

    5.3%

Reddit Mentions

Glaukos has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Glaukos is 89 out of 100 (very bullish).

  • Business Outlook

    89

  • Change from Previous Month

    0%

  • 3 Month Change

    1.1%

  • YoY Change

    1.1%

News Mentions

Glaukos was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

GKOS Financials

GKOS Key Metrics

  • Total Revenue

    $106.7M

  • Net Income

    -$18.1M

  • Earnings per Share

    -$0.32

  • Free cash flow

    -$20.5M

  • EBITDA

    -$20.7M

  • EBITDA Ratio

    -0.193861

  • Total Assets

    $966.2M

GKOS 2-year Revenue & Income
GKOS 2-year Free Cash Flow

GKOS Technicals

GKOS SMA
GKOS RSI

FAQ

What's the current price of Glaukos (GKOS) Stock?
The price of an Glaukos (GKOS) share is $94.05.

What's the market cap of Glaukos?
The current market cap of Glaukos is 5.4B.

Should I buy or sell GKOS?
Multiple alternative data signals suggest that Glaukos stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Glaukos a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Glaukos stock. The bullish indicators suggest that Glaukos' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Glaukos (GKOS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Glaukos stock, given the bullish outlook.

What are some stocks similar to Glaukos (GKOS) that investors often compare it to?
Glaukos (GKOS) is often compared to similar stocks such as Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Medtronic and Stryker.

What is the forecast for Glaukos' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Glaukos' stock price to be around $102.2 in 2026. Starting from the current price of $94.05, this represents a 8.7% change in price, indicating a bullish outlook for the stock.

How to buy Glaukos (GKOS) Stock?
Glaukos stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Glaukos shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.